Blue Earth Diagnostics,. (u.s.)

Blue Earth Diagnostics, Inc. is a molecular imaging company specializing in the development and commercialization of innovative radiopharmaceuticals for cancer diagnosis and management. Founded in 2014 and headquartered in Burlington, Massachusetts, the company focuses on advancing precision medicine through PET imaging agents, including its flagship product Axumin, used for detecting recurrent prostate cancer. Blue Earth Diagnostics generates revenue by developing and distributing these imaging agents to healthcare providers and institutions. Acquired by Bracco Imaging in 2019, the company benefits from its parent organization's global reach and expertise in diagnostic imaging.

Recent Posts by Blue Earth Diagnostics,. (u.s.)

1-7 of 7